- Type / Class
- Equity / Common Stock
- Shares outstanding
- 61,152,075
- Total 13F shares
- 62,595,716
- Share change
- +1,337,019
- Total reported value
- $9,312,956,409
- Put/Call ratio
- 151%
- Price per share
- $149.31
- Number of holders
- 218
- Value change
- +$237,478,312
- Number of buys
- 117
- Number of sells
- 93
Quarterly Holders Quick Answers
What is CUSIP 04351P101?
CUSIP 04351P101 identifies ASND - Ascendis Pharma A/S - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04351P101:
Top shareholders of ASND - Ascendis Pharma A/S - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
17%
|
10,108,400
|
$1,378,583,592 | — | 30 Jun 2024 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
8.1%
|
4,962,824
|
$676,829,960 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
8%
|
4,922,555
|
$671,338,051 | — | 30 Jun 2024 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
7%
|
4,295,029
|
$585,756,055 | — | 30 Jun 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
6.9%
|
4,196,661
|
$572,340,627 | — | 30 Jun 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
6.4%
|
3,918,813
|
$534,488,464 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
4.3%
|
2,612,856
|
$356,341,302 | — | 30 Jun 2024 | |
| Capital International Investors |
13F
|
Company |
3.4%
|
2,104,298
|
$286,984,161 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
3.4%
|
2,084,851
|
$284,332,033 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.9%
|
1,784,148
|
$243,323,000 | — | 30 Jun 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
2.8%
|
1,711,015
|
$233,348,226 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
1.8%
|
1,106,449
|
$150,897,515 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.3%
|
820,512
|
$111,901,427 | — | 30 Jun 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
1.2%
|
750,000
|
$102,285,000 | — | 30 Jun 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
1.2%
|
734,284
|
$100,141,652 | — | 30 Jun 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
1.1%
|
664,307
|
$90,598,189 | — | 30 Jun 2024 | |
| Spyglass Capital Management LLC |
13F
|
Company |
1.1%
|
662,888
|
$90,404,665 | — | 30 Jun 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.1%
|
660,662
|
$90,101,083 | — | 30 Jun 2024 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.98%
|
596,314
|
$81,325,303 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.88%
|
537,762
|
$73,339,981 | — | 30 Jun 2024 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.78%
|
478,676
|
$65,281,832 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.78%
|
475,001
|
$64,780,636 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.77%
|
473,449
|
$64,568,975 | — | 30 Jun 2024 | |
| FIL Ltd |
13F
|
Company |
0.72%
|
442,508
|
$60,349,241 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.69%
|
421,551
|
$57,491,125 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.66%
|
405,989
|
$55,368,779 | — | 30 Jun 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.57%
|
346,218
|
$47,217,211 | — | 30 Jun 2024 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.5%
|
307,073
|
$41,878,616 | — | 30 Jun 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.5%
|
305,974
|
$41,728,884 | — | 30 Jun 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.47%
|
290,000
|
$39,550,200 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.46%
|
281,537
|
$38,396,016 | — | 30 Jun 2024 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.43%
|
264,571
|
$36,082,205 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.42%
|
255,320
|
$34,820,542 | — | 30 Jun 2024 | |
| ARS Investment Partners, LLC |
13F
|
Company |
0.41%
|
253,139
|
$34,523,097 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.4%
|
246,961
|
$33,680,543 | — | 30 Jun 2024 | |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC |
13F
|
Company |
0.38%
|
233,673
|
$31,868,324 | — | 30 Jun 2024 | |
| Tri Locum Partners LP |
13F
|
Company |
0.37%
|
227,762
|
$31,062,182 | — | 30 Jun 2024 | |
| Q Global Advisors, LLC |
13F
|
Company |
0.36%
|
219,459
|
$29,930,000 | — | 30 Jun 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.33%
|
202,000
|
$27,548,760 | — | 30 Jun 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.33%
|
199,401
|
$27,194,308 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.33%
|
198,766
|
$27,107,707 | — | 30 Jun 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.32%
|
195,347
|
$26,640,181 | — | 30 Jun 2024 | |
| Finepoint Capital LP |
13F
|
Company |
0.31%
|
189,272
|
$25,812,915 | — | 30 Jun 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.31%
|
186,581
|
$25,445,917 | — | 30 Jun 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.3%
|
181,029
|
$24,688,735 | — | 30 Jun 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.29%
|
179,252
|
$24,446,356 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.27%
|
166,969
|
$22,771,311 | — | 30 Jun 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.27%
|
163,110
|
$22,245,000 | — | 30 Jun 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.26%
|
160,602
|
$21,902,901 | — | 30 Jun 2024 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.25%
|
151,656
|
$20,682,845 | — | 30 Jun 2024 |
Institutional Holders of Ascendis Pharma A/S - Common Stock (ASND) as of Q3 2024
As of 30 Sep 2024,
Ascendis Pharma A/S - Common Stock (ASND) was held by
218 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,595,716 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., WESTFIELD CAPITAL MANAGEMENT CO LP, Avoro Capital Advisors LLC, FMR LLC, Artisan Partners Limited Partnership, JANUS HENDERSON GROUP PLC, PRICE T ROWE ASSOCIATES INC /MD/, Capital International Investors, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, and T. Rowe Price Investment Management, Inc..
This page lists
219
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
202
Q3 2024 holders
218
Holder diff
16
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.